A constituent of cannabis known as cannabidiol could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial. The main psychoactive compound in cannabis is delta-9-tetrahydrocannabinol (THC), which is responsible for many of the drug’s harmful effects, such as paranoia and anxiety. […]
Cannabidiol could treat psychosis
